Skip to content
The Nexus
DossierENTITY

MW150

Coverage of MW150 in the Nexus archive.

Earliest in view: May 25 · 11:00 UTCMost recent: May 25 · 11:00 UTC
Co-mentioned in this coverage
Linda Van Eldikperson1Caleb Baileyperson1University of Kentucky's Sanders-Brown Center on Agingorganization1Alcohol (journal)organization1Alzheimer’s diseasetopic1alcohol use disordertopic1Neflamapimodtopic1
Recent coverage
  • HEALTHMay 25 · 11:00 UTCFOX NEWS
    Experimental Alzheimer’s drug could reduce alcohol withdrawal damage, researchers say

    An experimental Alzheimer’s drug called MW150 may reduce brain inflammation during alcohol withdrawal, potentially lowering relapse risks in alcohol use disorder. The study, led by University of Kentucky researchers, suggests MW150 could be repurposed for alcohol-related conditions if further trials confirm its efficacy.